Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

The St. Louis-born biopharmaceutical company has a new life and new focus, four months after its board sought to dissolve the ...

Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...

Shares of Puma Biotechnology, Inc. PBYI have rallied 24% in the past three months against the industry’s decline of 9.7%. The ...

Achieving biotech sovereignty will reduce dependency on foreign nations for critical products and technologies, ensuring ...

NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...

Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...

From proton therapy firsts to tumour-killing quantum dots, Tami Freeman shares her pick of this year’s healthcare innovations ...

The lungs are a tempting place for cancer cells -- so much so that more than half of people with advanced cancer elsewh ...

One company to watch right now is Puma Biotechnology (PBYI). PBYI is currently sporting a Zacks Rank of #1 (Strong Buy), as well as a Value grade of A. Another valuation metric that we should ...

The year 2025 will witness India assuming critical role in the global biotechnology revolution, and the first Bio-E3 policy ...

This post was written by Luke Carberry Mogan. If you’re looking for biotech stocks to buy, the iShares Biotechnology ETF (NASDAQ:IBB) is an excellent place to start. It tracks the performance of ...